{"version":"1.0","provider_name":"ZMUni Compliance Centre","provider_url":"https:\/\/www.zmuni.com\/en\/","author_name":"kim","author_url":"https:\/\/www.zmuni.com\/en\/news\/author\/kim\/","title":"China's NCI Approval Updates: Peptides Dominate Late July NCI Notifications","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"xjxYcLU6fK\"><a href=\"https:\/\/www.zmuni.com\/en\/news\/chinasnciapprovalupdatespeptidesdominatelatejulyncinotificat\/\">China's NCI Approval Updates: Peptides Dominate Late July NCI Notifications<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.zmuni.com\/en\/news\/chinasnciapprovalupdatespeptidesdominatelatejulyncinotificat\/embed\/#?secret=xjxYcLU6fK\" width=\"600\" height=\"338\" title=\"&#8220;China&#039;s NCI Approval Updates: Peptides Dominate Late July NCI Notifications&#8221; &#8212; ZMUni Compliance Centre\" data-secret=\"xjxYcLU6fK\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/cdn.zmuni.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/cdn.zmuni.com\/wp-content\/uploads\/2026\/08\/1785828051-50.jpg","thumbnail_width":2560,"thumbnail_height":1440,"description":"&nbsp; From July 21 to 31, a total of five new cosmetic ingredients completed notification with China&#39;s National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not yet been publicly disclosed. Notably, four of the five notified NCIs are peptides, comprising three cyclic peptides and one polypeptide. &nbsp; &nbsp; 3&#39;-Sialyllactose sodium salt &nbsp; 3&#39;-Sialyllactose sodium salt (3&#39;-SL) is composed of N-acetylneuraminic acid (Neu5Ac, also known as sialic acid), galactose, and glucose. As a human milk oligosaccharide (HMO), 3&#39;-SL has been approved by authorities such as the US and EU for use in infant formula and other"}